Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.


US Dollar Near Two-Month Low as Markets Await Inflation Data
US Judge Dismisses Gautam Adani Criminal Charges
UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing
Yen Stabilizes After Intervention Slide as Australian Dollar Hits Eight-Week High
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Australian Shares Fall as Westpac Slides, Miners Gain Ahead of RBA Decision
Eduardo Bolsonaro Granted U.S. Green Card Amid Brazil Legal Battle and Tariff Dispute
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Natura Q2 Profit Plunges 92% as Financial Expenses Weigh on Earnings
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Civil Rights Groups Sue Trump Administration Over Childcare Funding Freeze and Influencer's Role
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Bets
Juan Orlando Hernandez Seeks Dismissal of Honduras Charges After Trump Pardon
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 



